Combining neoadjuvant chemotherapy with PD-1/PD-L1 inhibitors for locally advanced, resectable gastric or gastroesophageal junction adenocarcinoma: A systematic review and meta-analysis. This evidence concerns the gene PDCD1 and gastroesophageal junction adenocarcinoma.